Blood cancers, Myeloma
Open
Phase 1
This trial is looking at adding a drug called belantamab mafodotin to usual treatment for myeloma.
It is for people whose myeloma has come back or treatment has stopped working.
Recruitment start: 11 May 2022
Recruitment end: 30 June 2026
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Rakesh Popat
GlaxoSmithKline Ltd
UKMRA-Myeloma UK-CARP
Last reviewed: 22 Dec 2025
CRUK internal database number: 15440
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
